Press Releases Year None202120202019201820172015 November 11, 2021 ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences November 10, 2021 ORIC Pharmaceuticals Appoints Angie You, Ph.D., to its Board of Directors November 8, 2021 ORIC Pharmaceuticals Reports Third Quarter 2021 Financial Results and Operational Update November 4, 2021 ORIC Pharmaceuticals to Present Update on CD73 Inhibitor Program in Multiple Myeloma at the American Society of Hematology (ASH) Annual Meeting October 7, 2021 ORIC Pharmaceuticals Presents Initial Clinical Data from Phase 1b Trial of ORIC-101 in Combination with Enzalutamide and Preclinical Data on ORIC-114 at AACR-NCI-EORTC September 30, 2021 ORIC Pharmaceuticals Announces Multiple Data Presentations at AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics September 21, 2021 ORIC Pharmaceuticals Announces Update on ORIC-533, a Highly Potent, Orally Bioavailable Small Molecule CD73 Inhibitor September 1, 2021 ORIC Pharmaceuticals to Participate in Upcoming Investor Conferences August 16, 2021 ORIC Pharmaceuticals Appoints Steven L. Hoerter to its Board of Directors August 10, 2021 ORIC Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Update Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 23
